Breast Cancer Research and Treatment. African-American AA patients with triple-negative breast cancer TNBC are less likely to achieve pathologic complete response from neoadjuvant chemotherapy and have poorer prognosis than Caucasian patients with TNBC, suggesting potential biological differences by race. Immune infiltration is the most consistent predictive marker for chemotherapy response and improved prognosis in TNBC. In this study, we test the hypothesis that the immune microenvironment differs between AA and Caucasian patients.
Comparing Breast Cancer Screening Rates Among Different Groups | Susan G. Komen®
White women and black women have the highest incidence rate of new breast cancer cases overall [ ]. The lifetime risk up to age 95 and older of breast cancer for women in the U. However, this risk varies by race and ethnic group. Lifetime risk of breast cancer.